VREX Earnings

VREX reported its earnings on 2026-05-07, showcasing a revenue of 216.00M against an estimate of 217.20M, resulting in a -0.55% surprise. The EPS was 0.21, surpassing the expected 0.22 by -4.55%. The stock experienced a -16.91% price change on the earnings day and a -14.88% change over the next five days, reflecting market reactions to the results.

Following VREX's earnings announcement on 2026-05-07, the stock price moved by -16.91% on the day of the release. Over the subsequent five days, it saw a -14.88% change. Historically, VREX's stock price tends to shift by an average of -1.16% in the 10 days leading up to earnings and -3.9% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate VREX's annual revenue to reach 215.00M, while the EPS is projected at 0.19. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between VREX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, VREX's stock price typically moves by -1.16% in the 10 days before its earnings and -3.9% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 0.19 and revenue of 215.00M.

The earnings call showed strong financial performance with a 5% revenue increase and improved gross margins. EPS also grew to $0.50, indicating robust profitability. The medical imaging segment's demand supports future growth. Although operating expenses rose, they were tied to R&D investments, which could drive innovation. No strategic initiatives or risks were discussed, leaving a neutral impact. Overall, the financial results and EPS improvement suggest a positive stock price movement.